By: Angela Garrity
The FDA’s Center for Tobacco Products issued a warning letter to Juul today over marketing modified risk tobacco products by engaging in labeling, advertising, and/or other activities directed to consumers.
The concerns and requests for documents and information come after two days of the July Congressional hearings, in which the Subcommittee on Economic and Consumer Policy of the Committee on Oversight and Reform of the United States House of Representatives questioned Juul over its outreach and marketing practices, such as, those targeted at students, tribes, health insurers, and employers.
The FDA also sent the manufacturer a separate letter requested more information about the company’s marketing practices.
The FDA is seeking a response from Juul Labs within 30 days.
Read the full announcement here.